Bifidobacterium infantis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

One study found that 6-8 weeks of Bifidobacterium infantis 35624 supplementation reduced C-reactive protein, TNF-alpha and IL-6 levels in chronic fatigue syndrome patients [1]. Another found that B. infantis boosted serotonin levels in the brain.[citation needed]

References

  1. Groeger, David; O'Mahony, Liam; Murphy, Eileen F.; Bourke, John F.; Dinan, Timothy G.; Kiely, Barry; Shanahan, Fergus; Quigley, Eamonn M.M. (August 2013), "Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut", Gut Microbes, 4 (4): 325–339, doi:10.4161/gmic.25487, ISSN 1949-0984, PMC 3744517, PMID 23842110